Evidence map›Paper›PMID 31393918›Full record

ArticlePloS one2019

Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity.

Janet Ugolino, Kristina M Dziki, Annette Kim, Josephine J Wu, Bruce E Vogel, Mervyn J Monteiro

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. ATP13A2 (PARK9) and basal ganglia function.Frontiers in neurology · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Janet UgolinoBiochemistry and Molecular Biology Graduate Program, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Kristina M DzikiCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Annette KimCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Josephine J WuCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Bruce E VogelCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Mervyn J MonteiroCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0002-1740-5309
University of Maryland, Baltimore · US

Funding

Mechanistic studies and therapeutics for ALS/FTD linked to UBQLN2 mutationsR01NS098243 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI Mervyn J Monteiro · 2017 to 2026
$4.0M
Deciphering the role of ER stress in ALS pathogenesis caused by UBQLN2 mutationsR01NS100008 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI MONTEIRO, MERVYN J · 2017 to 2021
$2.7M
Generation of a mouse model to monitor ERAD in neuronsR21NS095135 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI MONTEIRO, MERVYN J · 2016 to 2017
$424k
NINDS NIH HHS R01 NS098243NINDS NIH HHS R01 NS100008NINDS NIH HHS R21 NS095135
6 · The paper itself

Abstract

Mutations in ATP13A2 cause Kufor-Rakeb syndrome (KRS), a juvenile form of Parkinson's disease (PD) with dementia. However, the mechanisms by which mutations in ATP13A2 cause KRS is not understood. The mutations lead to misfolding of the translated Atp13a2 protein and its premature degradation in the endoplasmic reticulum, never reaching the lysosome where the protein is thought to function. Atp13a2 is a P-type ATPase, a class of proteins that function in ion transport. Indeed, studies of human, mouse, and yeast Atp13a2 proteins suggest a possible involvement in regulation of heavy metal toxicity. Here we report on the cytoprotective function of Atp13a2 on HeLa cells and dopamine neurons of Caenorhabditis elegans (C. elegans). HeLa cells stably overexpressing V5- tagged Atp13a2Isoform-1 protein were more resistant to elevated manganese exposure and to starvation-induced cell death compared to cells not overexpressing the protein. Because PD is characterized by loss of dopamine neurons, we generated transgenic C. elegans expressing GFP-tagged human Atp13a2 protein in dopamine neurons. The transgenic animals exhibited higher resistance to dopamine neuron degeneration after acute exposure to manganese compared to nematodes that expressed GFP alone. The results suggest Atp13a2 Isoform-1 protein confers cytoprotection against toxic insults, including those that cause PD syndromes.

Indexed as

Cell DeathStarvationAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansDopaminergic NeuronsHeLa CellsHumansManganeseParkinson DiseaseProtective AgentsProtein IsoformsProton-Translocating ATPasesATP13A2 protein, humanManganeseProtective AgentsProtein IsoformsProton-Translocating ATPases

Identifiers

PMID31393918
PMCPMC6687281
OpenAlexW2968908208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.